By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Deciphera Pharmaceuticals 

1505 Wakarusa Drive

Lawrence  Kansas  66047  U.S.A.
Phone: 785-838-3767 Fax: 785-838-3747


SEARCH JOBS


Industry
Pharmaceutical






Company News
Deciphera Pharmaceuticals To Present At The 14th Annual Needham Healthcare Conference 4/1/2015 3:25:59 PM
Deciphera Pharmaceuticals To Present At The JMP Securities Life Sciences Private Company Conference Series 3/24/2015 11:41:50 AM
Deciphera Pharmaceuticals To Present Data On Oncology Pipeline At American Association for Cancer Research Annual Meeting 2015 3/19/2015 10:37:27 AM
Deciphera Pharmaceuticals To Present At Future Leaders In The Biotech Industry Conference 3/17/2015 11:43:06 AM
Deciphera Pharmaceuticals Appoints Tucker Kelly As Chief Financial Officer 3/16/2015 10:41:31 AM
Deciphera Pharmaceuticals Presents Data On Altiratinib (DCC-2701), An Advanced Multi-Targeted Kinase Inhibitor, At 26th EORTC-NCI-AACR Symposium On Molecular Targets And Cancer Therapeutics 11/20/2014 11:21:05 AM
Deciphera Pharmaceuticals Presents Data On Altiratinib (DCC-22701) That Demonstrated Inhibition Of Tumor Growth And Invasion In Bevacizumab Resistant Glioblastoma 11/17/2014 11:31:02 AM
Deciphera Pharmaceuticals Appoints Oliver Rosen M.D. As Chief Medical Officer 6/30/2014 9:51:30 AM
Deciphera Pharmaceuticals Announces Initiation Of Phase 1 Cancer Trial For Altiratinib (DCC-2701) MET/TIE2/VEGFR/TRK Kinase Inhibitor For Solid Tumors 5/30/2014 9:36:50 AM
Deciphera Pharmaceuticals Appoints Michael D. Taylor, Ph.D., As President And Chief Executive Officer 4/7/2014 3:01:53 PM
12
//-->